Causes of discordance between thyroglobulin antibody assays
Authors:
Open Access
- 24 July 2012
- journal article
- research article
- Published by SAGE Publications in Annals of Clinical Biochemistry: International Journal of Laboratory Medicine
- Vol. 49 (5) , 463-467
Abstract
Background: Anti-thyroglobulin (Anti-Tg) assays show poor concordance. Methods: We have investigated concordance and the causes of discordance between Abbott, Roche and Immulite Anti-Tg assays in 606 patients followed up for differentiated thyroid cancer (DTC). The reference range (RR) or lower reporting limit (LRL) was used to classify samples as negative or positive. Results: Anti-Tg prevalence ranged between 6% and 55% depending on the method and cut-off. Concordance was 45% using LRL and 75% using RR. Specimens between the RR and LRL using the Immulite and Roche assays were identified that were positive by the Abbott assay and showed poor recovery of Tg in the Tg assay. This suggests misclassification using the RR. Anti-Tg International Reference Preparation (IRP) concentrations measured by the Roche and Abbott methods agreed well but patient samples did not. This is likely to be due to the heterogeneity of Anti-Tg. The Immulite assay appeared less sensitive than the Abbott and Roche based on investigations using the IRP and the low prevalence of Anti-Tg in the DTC patients (6–8%). Interference by Tg (>1000 μg/L) in the Roche assay was also identified as a cause of assay discordance. Conclusions: Anti-Tg is used as a tumour marker for DTC and to predict interference in Tg assays themselves and hence inform clinicians of reported Tg concentrations. We have identified several causes of Anti-Tg assay discordance. This includes variation in assay sensitivity and interference from Tg, the heterogeneity of Anti-Tg and the use of different cut-offs to classify samples as antibody-positive or -negative.Keywords
This publication has 6 references indexed in Scilit:
- Current Thyroglobulin Autoantibody (TgAb) Assays Often Fail to Detect Interfering TgAb that Can Result in the Reporting of Falsely Low/Undetectable Serum Tg IMA Values for Patients with Differentiated Thyroid CancerThe Journal of Clinical Endocrinology & Metabolism, 2011
- Concordance between thyroglobulin antibody assaysAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2011
- Thyroglobulin and anti-thyroglobulin assays in thyroid cancer monitoringClinical Biochemistry, 2009
- Performance characteristics of 5 automated thyroglobulin autoantibody and thyroid peroxidase autoantibody assaysClinica Chimica Acta, 2007
- Clinical Impact of Thyroglobulin (Tg) and Tg Autoantibody Method Differences on the Management of Patients with Differentiated Thyroid CarcinomasThe Journal of Clinical Endocrinology & Metabolism, 2005
- Serum thyroglobulin (Tg) in presence of thyroglobulin autoantibodies (TgAb). Clinical and methodological relevance of the interaction between Tg and TgAb in vitro and in vivoJournal of Endocrinological Investigation, 1985